Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Investigating Out-of-Specification (OOS) Test Results in the Laboratory; FDA Guidance and Latest Expectations" webinar has been added to ResearchAndMarkets.com's offering.
Inadequate investigation of out-of-specification (OOS) results in the laboratory is a common observation cited in FDA 483s and Warning Letters. It is clear that regulatory investigators throughout the world are looking at laboratory operations very closely.
The objective of this live training webinar is to develop an understanding of how a compliant laboratory handles the investigation of OOS test observations and how the laboratory interfaces with other units through the laboratory investigation process. The interactive live discussion will be based on the FDA guidance on handling OOS laboratory results and to provide a clear process for compliant laboratory OOS investigations.
Webinar Takeaway
Learning Benefits:
Regulations and Guidances that will be covered (FDA, EU, Canada, WHO, ICH, other):
Who Should Attend:
For more information about this webinar visit https://www.researchandmarkets.com/r/pccqmx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.